Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Hopkins et al, 1995
Eli Lilly announced that Retatrutidethe first-in-class GIP, GLP-1, and glucagon triple agonistachieved an average weight loss of 28.7% at 68 weeks in the TRIUMPH-4 Phase 3 trial
The company said its own self-pay program removes third-party supply chain entities, "allowing patients to access savings directly outside of insurance." "Every major medical organization and establishment recognizes obesity as a chronic disease, yet insurance and federal programs do not systematically cover people living with obesity for medical care this needs to change," Patrik Jonsson, president of Lilly Cardiometabolic Health, said in a statement
Compounded tirzepatide often comes in amber-colored vials or is wrapped in protective packaging
Home blood pressure monitors are inexpensive and reliable tools for tracking changes between clinic visits
US$ 27.79
US$ 22.60
US$ 28.53
US$ 21.21
US$ 27.64
US$ 25.35
